Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer.
- Published in:
- Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, p. S556, doi. 10.1080/21691401.2018.1501380
- By:
- Publication type:
- Article